Merck (MRK) Tops Q1 EPS by 20c; offers guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $119.60 +3.57%
Revenue Growth %: +3.5%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q1 EPS of ($1.28), $0.20 better than the analyst estimate of ($1.48). Revenue for the quarter came in at $16.29 billion versus the consensus estimate of $15.89 billion.
GUIDANCE:
Merck sees FY2026 EPS of $5.04-$5.16, versus the consensus of $5.11. Merck sees FY2026 revenue of $65.8-67 billion, versus the consensus of $66.493 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Boeing wins $2 billion satellite contract from DoW
- Lockheed Martin wins $8.4B missile contract modification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
